Search results for "Highlights"
Guidance offered on management of extraesophageal GERD
The clinical practice update from the American Gastroenterological Association was based on a review of the evidence and expert opinion regarding extraesophageal symptoms of gastroesophageal reflux disease (GERD).
https://gastroenterology.acponline.org/archives/2023/04/21/2.htm
21 Apr 2023
DPP-4 inhibitors associated with risk of cholecystitis, meta-analysis finds
Patients with type 2 diabetes who were randomized to receive dipeptidyl peptidase-4 (DPP-4) inhibitors had higher rates of gallbladder disease than those who got placebo or nonincretin drugs, but no difference in risk of cholelithiasis or biliary diseases.
https://gastroenterology.acponline.org/archives/2022/07/22/6.htm
22 Jul 2022
IV iron regimens compared for serum phosphate effects in patients with IBD
Ferric carboxymaltose and ferric derisomaltose worked well to resolve anemia from inflammatory bowel disease (IBD), but the former was associated with low serum phosphate levels, according to an industry-funded trial.
https://gastroenterology.acponline.org/archives/2022/09/23/2.htm
23 Sep 2022
Electronic alert about lactulose linked to lower readmissions in patients with cirrhosis
The alert, which encouraged clinicians to prescribe rifaximin for patients with cirrhosis and hepatic encephalopathy who were on lactulose, increased uptake of rifaximin in such patients.
https://gastroenterology.acponline.org/archives/2022/01/28/3.htm
28 Jan 2022
New guideline offers recommendations on managing antithrombotic drugs during GI bleeds, endoscopies
The American College of Gastroenterology and the Canadian Association of Gastroenterology offered suggestions for management of patients on warfarin, direct oral anticoagulants, and antiplatelet agents.
https://gastroenterology.acponline.org/archives/2022/03/25/1.htm
25 Mar 2022
Heart failure risk increased in patients with NAFLD, meta-analysis finds
Nonalcoholic fatty liver disease (NAFLD) was associated with a 50% increased risk of new-onset heart failure, independent of age, sex, diabetes, hypertension, and other common cardiovascular risk factors, according to an international meta-analysis.
https://gastroenterology.acponline.org/archives/2022/08/26/2.htm
26 Aug 2022
HCV medications decreased liver disease among those using injection drugs
A Baltimore-based study found that half of participants with chronic hepatitis C virus (HCV) and a history of injection drug use at baseline were free of the virus by 2019, with associated reductions in their risk of cirrhosis and mortality.
https://gastroenterology.acponline.org/archives/2022/07/22/2.htm
22 Jul 2022
Excess weight over time associated with increased CRC risk
A German study found that the weighted number of years lived with overweight and obesity was associated with a higher risk for colorectal cancer (CRC) than excess body mass index at a single point in time.
https://gastroenterology.acponline.org/archives/2022/03/25/3.htm
25 Mar 2022
Review finds only two efficacious medications to treat gastroparesis
Clebopride ranked first for efficacy, followed by domperidone, and no other drug was superior to placebo for improving symptoms of gastroparesis, according to a recent meta-analysis.
https://gastroenterology.acponline.org/archives/2023/01/27/2.htm
27 Jan 2023
Patient navigation associated with increased care, treatment in hepatitis C
A pre-post study in a safety-net health system found higher odds of linkage to care and direct-acting antiviral treatment in older adults who received patient navigation rather than usual care.
https://gastroenterology.acponline.org/archives/2022/05/27/3.htm
27 May 2022